KRRO Korro Bio, Inc. - Common Stock
NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 6, 2026
$9,64
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$5,20minimo 52 sett.
$55,89massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$142M
P/E (TTM)
-1.0
EPS (TTM)
$-10.01
Ricavi (TTM)
$2M
i tuoi badge
Intervallo 52 sett.
$5–$56
Rating Analisti
BUY
Prezzo Obiettivo
$20
P/E
-1.0
ROE
-97.7%
Margine di Profitto Netto
-4477.1%
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
KRRO Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$9.64
Capitalizzazione di Mercato (MRQ)
$142M
P/E (TTM)
-1.0
EPS (TTM)
$-10.01
Ricavi (TTM)
$2M
ROE (TTM)
-97.7%
Intervallo 52 sett.
$5–$56
KRRO Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Split azionari
| Data ex-dividendo | Split | Tipo |
|---|---|---|
| 06 Novembre 2023 | 1-for-50 | Inverso |
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi$6M2019-12-31 → 2025-12-31
EPS$-12.482022-12-31 → 2025-12-31
Flusso di cassa libero$-79M2019-12-31 → 2025-12-31
Margine netto-4477.1%2019-12-31 → 2025-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | KRRO | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E (TTM) | -1.0media 5 anni ≈-1.6 | ≈-1.6 | · | · | |
| P/S (TTM) | 59.5media 5 anni ≈266.7 | ≈266.7 | 29.5 | Sopravvalutato | |
| P/B (MRQ) | 1.4media 5 anni ≈18.5 | ≈18.5 | 1.9 | Valore equo | |
| Prezzo / FCF (TTM) | -2.1media 5 anni ≈-30.8 | ≈-30.8 | · | · | |
| Prezzo / Flusso di cassa (TTM) | -2.1media 5 anni ≈-32.3 | ≈-32.3 | · | · | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 2.7media 5 anni ≈2.0 | ≈2.0 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | KRRO | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Margine Operativo (TTM) | -4625.5%media 5 anni ≈-2183.6% | ≈-2183.6% | -1906.4% | In linea | |
| EBITDA Margin (Margine EBITDA) | -1906.4%media 5 anni ≈-2183.6% | ≈-2183.6% | -1906.4% | In linea | |
| Margine ante imposte (TTM) | -4441.9%media 5 anni ≈-2033.5% | ≈-2033.5% | -3650.4% | Di prim'ordine | |
| Margine di Profitto Netto (TTM) | -4477.1%media 5 anni ≈-2038.9% | ≈-2038.9% | -1834.5% | In linea | |
| ROA (TTM) | -62.0%media 5 anni ≈-49.7% | ≈-49.7% | -69.0% | In linea | |
| ROE (TTM) | -97.7%media 5 anni ≈-306.4% | ≈-306.4% | -81.2% | Debole | |
| ROIC | -238.2%media 5 anni ≈-102.3% | ≈-102.3% | -75.7% | Debole |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | KRRO | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 9.6media 5 anni ≈9.1 | ≈9.1 | 6.5 | Liquidità elevata | |
| Quick Ratio | 6.3media 5 anni ≈7.6 | ≈7.6 | 4.1 | Liquidità elevata |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
| Metrica | Tendenza 5 anni | KRRO | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue YoY (Ricavi YoY) | 181.5% | · | · | · | |
| Revenue CAGR 3Y (CAGR Ricavi 3Y) | -45.6% | · | · | · | |
| Revenue CAGR 5Y (CAGR Ricavi 5Y) | -29.6% | · | · | · |
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | KRRO | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 0.0media 5 anni ≈0.0 | ≈0.0 | 0.0 | Di prim'ordine | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$112.1K | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
14.7%
Prossimo report
Nov 10, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Ago 18, 2026 | $-1.07 | $-1.48 | 27.7% |
| 31 Marzo 2026 | Mag 19, 2026 | $-1.69 | $-1.88 | 10.0% |
| 31 Dicembre 2025 | $-1.65 | $-2.11 | 21.7% | |
| 30 Settembre 2025 | $-1.92 | $-2.65 | 27.4% | |
| 30 Giugno 2025 | $-2.74 | $-2.62 | -4.8% | |
| 31 Marzo 2025 | $-2.49 | $-2.66 | 6.2% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6M | $2M | $0 | $0 | $14M | $37M | $29M | |
| R&D Expense | $66M | $64M | $57M | $42M | $61M | $37M | $19M | |
| SG&A Expense | $28M | $31M | $27M | $17M | $37M | $27M | $15M | |
| Operating Expenses | $128M | $94M | $85M | $59M | $98M | $65M | $50M | |
| Operating Income | $-122M | $-92M | $-85M | $-59M | $-84M | $-28M | $-21M | |
| Interest Expense | · | · | · | $961.0K | $764.0K | $0 | · | |
| Interest Income | · | · | · | $1M | $397.0K | $994.0K | $2M | |
| Other Non-op | $5M | $8M | $3M | $976.0K | $-266.0K | · | · | |
| Pretax Income | $-117M | $-83M | $-81M | $-58M | $-85M | $-26M | $-19M | |
| Income Tax | $637.0K | $141.0K | $27.0K | $10.0K | $15.0K | $35.0K | $0 | |
| Net Income | $-117M | $-84M | $-81M | $-58M | $-85M | $-27M | $-19M | |
| EPS (Basic) | $-12.48 | $-9.37 | $-53.08 | $-227.42 | · | · | · | |
| EPS (Diluted) | $-12.48 | $-9.37 | $-53.08 | $-227.42 | · | · | · | |
| Shares (Basic) | 9,395,402 | 8,920,561 | 1,529,321 | 255,175 | · | · | · | |
| Shares (Diluted) | 9,395,402 | 8,920,561 | 1,529,321 | 255,175 | · | · | · | |
| EBITDA | $-122M | $-92M | $-85M | · | $-84M | $-28M | $-21M |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $22M | $56M | $166M | $36M | $80M | $220M | $200M | |
| Short-term Investments | $53M | $70M | $0 | $19M | · | · | · | |
| Prepaid Expense | $6M | $4M | $3M | $1M | $4M | $5M | $4M | |
| Other Current Assets | · | · | · | $255.0K | $185.0K | $102.0K | $199.0K | |
| Current Assets | $82M | $132M | $173M | $57M | $135M | $225M | $221M | |
| PP&E (Net) | $8M | $28M | $16M | $10M | $6M | $7M | $2M | |
| PP&E (Gross) | $19M | $35M | $24M | $14M | $10M | $10M | $4M | |
| Accum. Depreciation | $11M | $7M | $8M | $4M | $4M | $3M | $2M | |
| Other Non-current Assets | $2M | $3M | $3M | $228.0K | · | · | $101.0K | |
| Total Assets | $114M | $226M | $222M | $74M | $185M | $265M | $223M | |
| Accounts Payable | $2M | $4M | $7M | $3M | $3M | $6M | $1M | |
| Accrued Liabilities | $8M | $6M | $10M | $3M | $6M | $7M | $3M | |
| Current Liabilities | $12M | $15M | $19M | $9M | $11M | $27M | $53M | |
| Capital Leases | $41M | $43M | $31M | $209.0K | $29M | $31M | · | |
| Other Non-current Liabilities | $1M | $1M | $1M | $0 | $87.0K | · | · | |
| Total Liabilities | $62M | $66M | $52M | $9M | $55M | $72M | $56M | |
| Total Debt | · | · | · | · | $833.0K | · | $180.0K | |
| Common Stock | $9.0K | $9.0K | $8.0K | $0 | $35.0K | $34.0K | $31.0K | |
| Paid-in Capital | $435M | $427M | $353M | $3M | $311M | $288M | $236M | |
| Retained Earnings | $-384M | $-267M | $-183M | $-102M | $-180M | $-95M | $-69M | |
| AOCI | $212.0K | $268.0K | $0 | $-5.0K | $-62.0K | $27.0K | $54.0K | |
| Stockholders' Equity | $51M | $160M | $170M | $-99M | $-42M | $192M | $167M | |
| Liabilities + Equity | $114M | $226M | $222M | $74M | $185M | $265M | $223M | |
| Shares Outstanding | 9,417,295 | 9,377,259 | 8,016,516 | 268,399 | 237,803 | 33,964,000 | 30,844,507 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | · | · | · | $20M | $22M | $10M | $4M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Restructuring | $4M | $0 | · | · | · | · | · | |
| Operating Cash Flow | $-79M | $-60M | $-67M | $-54M | $-76M | $-45M | $34M | |
| CapEx | $518.0K | $18M | $8M | $5M | $3M | $7M | $1M | |
| Investing Cash Flow | $44M | $-123M | $11M | $11M | $-66M | $10M | $-18M | |
| Debt Issued | · | · | · | · | · | $15M | · | |
| Net Debt Issued | · | · | · | · | · | $15M | · | |
| Stock Issued | · | $0 | $117M | $0 | $1M | $2M | $80M | |
| Net Stock Activity | · | $0 | $117M | · | $1M | $2M | $80M | |
| Financing Cash Flow | $685.0K | $69M | $188M | $18.0K | $1M | $57M | $142M | |
| Net Change in Cash | $-34M | $-114M | $132M | $-43M | $-141M | $22M | $158M | |
| Taxes Paid | $1.0K | $141.0K | $27.0K | $11.0K | · | · | $94.0K | |
| Free Cash Flow | $-79M | $-78M | $-75M | · | $-79M | $-52M | $33M | |
| Levered FCF | · | · | · | · | $-80M | · | · |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1906.4% | -4047.1% | · | · | -597.3% | -74.5% | -71.4% | |
| Net Margin | -1834.5% | -3680.4% | · | · | -602.0% | -71.7% | -64.8% | |
| Pretax Margin | -1824.5% | -3674.2% | · | · | -601.9% | -71.6% | · | |
| EBITDA Margin | -1906.4% | -4047.1% | · | · | -597.3% | -74.5% | -71.4% | |
| ROA | -69.0% | -37.3% | -55.0% | · | -37.6% | -10.9% | -14.0% | |
| ROE | -140.8% | -49.2% | -974.8% | · | -60.9% | -13.5% | -34.8% | |
| ROIC | -238.2% | -57.4% | -49.8% | · | -63.8% | -14.3% | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.9 | 8.8 | 8.9 | · | 11.8 | 8.5 | 4.2 | |
| Quick Ratio | 6.3 | 8.4 | 8.5 | · | 7.0 | 8.3 | 3.8 | |
| Debt / Equity | · | · | · | · | 0.0 | · | 0.0 | |
| LT Debt / Equity | · | · | · | · | · | · | 0.0 | |
| Interest Coverage | · | · | · | · | -110.0 | · | · |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.2 | 0.2 |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.46 | $17.11 | $21.20 | · | $3.78 | $5.67 | $5.43 | |
| Revenue / Share | $0.68 | $0.25 | $0.00 | · | · | · | · | |
| Cash Flow / Share | $-8.36 | $-6.73 | $-44.00 | · | · | · | · | |
| Cash / Share | $2.32 | $5.93 | $20.73 | · | $2.30 | $6.49 | $6.49 | |
| EPS (TTM) | $-12.48 | $-9.37 | $-53.08 | $-227.42 | · | · | · |
Tassi di Crescita
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 181.5% | · | · | · | -62.0% | · | · | |
| Revenue CAGR 3Y | · | -45.6% | · | · | · | · | · | |
| Revenue CAGR 5Y | -29.6% | · | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6M | $2M | $0 | $0 | $14M | $37M | $29M | |
| Net Income TTM | $-117M | $-84M | $-81M | $-58M | $-85M | $-27M | $-19M | |
| Market Cap | $75M | $357M | $384M | · | $8.88B | $59.88B | $27.04B | |
| Enterprise Value | · | · | · | · | $8.80B | · | $26.84B | |
| P/E | -0.6 | -4.1 | -0.9 | -0.8 | · | · | · | |
| P/S | 11.8 | 157.2 | · | · | 631.1 | 1619.0 | 934.0 | |
| P/B | 1.5 | 2.2 | 2.3 | · | 67.9 | 311.1 | 161.5 | |
| P / Tangible Book | 1.5 | 2.2 | 2.3 | · | · | 311.1 | · | |
| P / Cash Flow | -1.0 | -5.9 | -5.7 | · | -116.7 | -1325.1 | 790.2 | |
| P / FCF | -1.0 | -4.6 | -5.1 | · | -112.4 | -1154.6 | 815.5 | |
| EV / EBITDA | · | · | · | · | -104.7 | · | -1298.0 | |
| EV / FCF | · | · | · | · | -111.4 | · | 809.5 | |
| EV / Revenue | · | · | · | · | 625.5 | · | 927.0 | |
| Earnings Yield | -155.8% | -24.6% | -110.7% | -118.1% | · | · | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $1M | $1M | $1M | $3M | $2M | $0 | $0 | $0 | · | · | · | · | · | $0 | |
| R&D Expense | $14M | $13M | $11M | $14M | $20M | $20M | $17M | $16M | $17M | $14M | $15M | $14M | $13M | $15M | $3M | $12M | |
| SG&A Expense | $7M | $7M | $6M | $7M | $7M | $8M | $8M | $7M | $7M | $8M | $11M | $5M | $5M | $5M | $-9M | $9M | |
| Operating Expenses | $20M | $20M | $52M | $20M | $29M | $28M | $25M | $23M | $24M | $21M | $27M | $19M | $18M | $20M | $-6M | $20M | |
| Operating Income | $-20M | $-20M | $-50M | $-19M | $-27M | $-25M | $-23M | $-23M | $-24M | $-21M | $-27M | $-19M | $-18M | $-20M | $6M | $-20M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $284.0K | · | $263.0K | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | $448.0K | $346.0K | $523.0K | · | $351.0K | |
| Other Non-op | $1M | $906.0K | $990.0K | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $656.0K | $786.0K | $481.0K | $619.0K | $617.0K | |
| Pretax Income | $-19M | $-20M | $-49M | $-18M | $-26M | $-23M | $-21M | $-21M | $-22M | $-20M | $-25M | $-18M | $-18M | $-20M | $6M | $-20M | |
| Income Tax | $108.0K | $95.0K | $636.0K | $0 | $1.0K | $0 | $103.0K | $-9.0K | $30.0K | $17.0K | $0 | $0 | $27.0K | $0 | $19.0K | $-23.0K | |
| Net Income | $-19M | $-20M | $-50M | $-18M | $-26M | $-23M | $-21M | $-21M | $-22M | $-20M | $-25M | $-18M | $-18M | $-20M | $6M | $-20M | |
| EPS (Basic) | $-1.07 | $-1.69 | $-5.33 | $-1.92 | $-2.74 | $-2.49 | $-2.24 | $-2.26 | $-2.43 | $-2.44 | $148.03 | $-65.08 | $-63.83 | $-72.20 | $-225.59 | $-0.55 | |
| EPS (Diluted) | $-1.07 | $-1.69 | $-5.33 | $-1.92 | $-2.74 | $-2.49 | $-2.24 | $-2.26 | $-2.43 | $-2.44 | $148.03 | $-65.08 | $-63.83 | $-72.20 | $-225.59 | $-0.55 | |
| Shares (Basic) | 17,618,441 | 11,598,717 | · | 9,391,559 | 9,390,542 | 9,384,266 | · | 9,303,218 | 8,986,545 | 8,019,626 | · | 284,156 | 276,482 | 271,522 | · | 35,247,680 | |
| Shares (Diluted) | 17,618,441 | 11,598,717 | · | 9,391,559 | 9,390,542 | 9,384,266 | · | 9,303,218 | 8,986,545 | 8,019,626 | · | 284,156 | 276,482 | 271,522 | · | 35,247,680 | |
| EBITDA | $-20M | $-20M | · | $-19M | $-27M | $-25M | · | $-23M | $-24M | $-21M | · | $-13M | $-12M | $-21M | · | $-20M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $25M | $62M | $22M | $24M | $34M | $64M | $56M | $63M | $91M | $139M | $166M | $42M | $40M | $41M | $36M | $44M | |
| Short-term Investments | $90M | $52M | $53M | $68M | $63M | $51M | $70M | $74M | $66M | · | $0 | · | · | · | $19M | · | |
| Prepaid Expense | $6M | $6M | $6M | $5M | $5M | $4M | $4M | $4M | $4M | $3M | $3M | $423.0K | $2M | $3M | $1M | $2M | |
| Current Assets | $121M | $120M | $82M | $98M | $103M | $121M | $132M | $153M | $164M | $146M | $173M | $42M | $48M | $69M | $57M | $101M | |
| PP&E (Net) | $7M | $8M | $8M | $24M | $25M | $27M | $28M | $29M | $25M | $21M | $16M | $543.0K | $1M | $2M | $10M | $3M | |
| PP&E (Gross) | $19M | $19M | $19M | $35M | $35M | $35M | $35M | $39M | $34M | $29M | $24M | $4M | $9M | $9M | $14M | $9M | |
| Accum. Depreciation | $11M | $11M | $11M | $11M | $10M | $9M | $7M | $10M | $9M | $9M | $8M | $3M | $8M | $7M | $4M | $6M | |
| Other Non-current Assets | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $3M | $2M | $3M | · | · | · | $228.0K | · | |
| Total Assets | $163M | $184M | $114M | $162M | $180M | $202M | $226M | $244M | $250M | $198M | $222M | $46M | $79M | $102M | $74M | $136M | |
| Accounts Payable | $4M | $2M | $2M | $2M | $5M | $4M | $4M | $6M | $6M | $5M | $7M | $338.0K | $1M | $3M | $3M | $4M | |
| Accrued Liabilities | $5M | $10M | $8M | $6M | $6M | $4M | $6M | $5M | $6M | $5M | $10M | $8M | $5M | $6M | $3M | $5M | |
| Current Liabilities | $13M | $15M | $12M | $15M | $17M | $13M | $15M | $14M | $12M | $11M | $19M | $10M | $8M | $22M | $9M | $20M | |
| Capital Leases | $39M | $40M | $41M | $42M | $42M | $43M | $43M | $42M | $38M | $35M | $31M | $0 | $26M | $26M | $209.0K | $27M | |
| Other Non-current Liabilities | $2M | $1M | $1M | $2M | $1M | $1M | $1M | $717.0K | $1M | $893.0K | $1M | $0 | $0 | $0 | $0 | $79.0K | |
| Total Liabilities | $60M | $64M | $62M | $63M | $65M | $63M | $66M | $64M | $52M | $47M | $52M | $10M | $34M | $48M | $9M | $54M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $12M | · | $8M | |
| Common Stock | $14.0K | $14.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $8.0K | $8.0K | $37.0K | $36.0K | $36.0K | $0 | $35.0K | |
| Paid-in Capital | $526M | $523M | $435M | $433M | $431M | $429M | $427M | $424M | $422M | $354M | $353M | $340M | $337M | $334M | $3M | $327M | |
| Retained Earnings | $-422M | $-403M | $-384M | $-334M | $-316M | $-290M | $-267M | $-245M | $-224M | $-203M | $-183M | $-304M | $-292M | $-281M | $-102M | $-244M | |
| AOCI | $-189.0K | $5.0K | $212.0K | $214.0K | $177.0K | $264.0K | $268.0K | $574.0K | $21.0K | · | $0 | $10.0K | $-6.0K | $-64.0K | $-5.0K | $-376.0K | |
| Stockholders' Equity | $103M | $120M | $51M | $99M | $115M | $139M | $160M | $180M | $198M | $151M | $170M | $37M | $45M | $53M | $-99M | $82M | |
| Liabilities + Equity | $163M | $184M | $114M | $162M | $180M | $202M | $226M | $244M | $250M | $198M | $222M | $46M | $79M | $102M | $74M | $136M | |
| Shares Outstanding | 14,705,646 | 14,422,571 | 9,417,295 | 9,397,984 | 9,390,842 | 9,388,902 | 9,377,259 | 9,318,356 | 9,279,937 | 8,022,463 | 8,016,516 | 36,926,285 | 35,963,706 | 35,751,956 | 268,468 | 35,262,233 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | · | · | · | · | · | · | · | · | · | · | · | $3M | $3M | $3M | · | $6M | |
| Restructuring | $0 | · | · | · | $1M | · | · | · | · | · | · | $0 | $359.0K | $4M | · | · | |
| Operating Cash Flow | $-17M | $-16M | $-18M | $-17M | $-19M | $-24M | $-7M | $-16M | $-15M | $-22M | $-21M | $-24M | $-20M | $-20M | $-11M | $-12M | |
| CapEx | $37.0K | $21.0K | $84.0K | $175.0K | $140.0K | $119.0K | $1M | $5M | $6M | $6M | $2M | $6M | $6M | $2M | $5M | $-16.0K | |
| Investing Cash Flow | $-18M | $-32M | $15M | $8M | $-11M | $33M | $-3M | $-13M | $-102M | $-6M | $-2M | $-12M | $7M | $15M | $4M | $13M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $-2M | · | · | |
| Stock Issued | $-3M | $83M | · | · | $0 | $0 | · | $0 | · | · | $117M | $-1.0K | $-1.0K | $1.0K | $-60.0K | $-1.0K | |
| Net Stock Activity | · | $83M | · | · | · | · | · | · | · | · | · | · | · | $1.0K | · | · | |
| Financing Cash Flow | $-3M | $88M | $380.0K | $128.0K | $5.0K | $172.0K | $932.0K | $728.0K | $68M | $139.0K | $145M | $57M | $48M | $45M | $-238.0K | $56.0K | |
| Net Change in Cash | $-38M | $40M | $-2M | $-9M | $-31M | $9M | $-9M | $-28M | $-49M | $-27M | $122M | $22M | $34M | $41M | $-7M | $1M | |
| Taxes Paid | $60.0K | $48.0K | $0 | $0 | $1.0K | $0 | $94.0K | $0 | $30.0K | $17.0K | $0 | $0 | $27.0K | $0 | · | · | |
| Free Cash Flow | · | $-16M | · | · | · | $-25M | · | · | · | $-28M | · | · | · | $-14M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | $-15M | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -1764.9% | -1863.1% | -981.2% | · | · | · | · | · | · | · | -18313.4% | · | · | |
| Net Margin | · | · | · | -1657.0% | -1765.1% | -917.1% | · | · | · | · | · | · | · | -17449.1% | · | · | |
| Pretax Margin | · | · | · | -1657.0% | -1765.0% | -917.1% | · | · | · | · | · | · | · | -17427.7% | · | · | |
| EBITDA Margin | · | · | · | -1764.9% | -1863.1% | -981.2% | · | · | · | · | · | · | · | -18313.4% | · | · | |
| ROA | -11.0% | -10.2% | · | -8.9% | -12.0% | -11.7% | · | -14.5% | -13.3% | -13.1% | · | -12.7% | -9.4% | -14.7% | · | -11.6% | |
| ROE | -17.3% | -15.2% | · | -13.0% | -16.5% | -16.1% | · | -19.4% | -17.9% | -19.1% | · | -19.6% | -15.3% | -23.6% | · | -17.1% | |
| ROIC | -19.6% | -17.2% | · | -19.4% | -23.6% | -18.0% | · | -13.0% | -12.2% | -14.2% | · | -34.4% | -26.1% | -31.6% | · | -22.4% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.6 | 8.1 | · | 6.7 | 6.0 | 9.4 | · | 11.2 | 13.3 | 13.2 | · | 4.4 | 5.8 | 3.1 | · | 5.0 | |
| Quick Ratio | 9.1 | 7.7 | · | 6.3 | 5.6 | 8.9 | · | 10.1 | 12.8 | 12.6 | · | 4.3 | 4.8 | 1.9 | · | 2.2 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.2 | · | 0.1 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | · | -72.2 | · | -77.1 |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | · | · | · | · | · | 0.0 | · | 0.0 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.02 | $8.29 | · | $10.54 | $12.26 | $14.80 | · | $19.28 | $21.34 | $18.87 | · | $0.99 | $1.26 | $1.49 | · | $2.32 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.12 | $0.16 | $0.27 | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $-1.39 | · | · | · | $-2.61 | · | · | · | $-2.73 | · | · | · | · | · | · | |
| Cash / Share | $1.69 | $4.28 | · | $2.57 | $3.58 | $6.83 | · | $6.78 | $9.82 | $17.30 | · | $1.13 | $1.10 | $1.14 | · | $1.24 | |
| EPS (TTM) | $-10.01 | $-11.68 | · | $-9.39 | $-9.73 | $-9.42 | · | $140.90 | $78.08 | $16.68 | · | $-426.70 | $-362.17 | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $4M | · | $7M | $6M | $5M | · | · | · | · | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-107M | $-113M | · | $-88M | $-91M | $-87M | · | $-88M | $-85M | $-81M | · | $-50M | $-51M | $-54M | · | $-86M | |
| Market Cap | $194M | $163M | · | $450M | $117M | $163M | · | $311M | $314M | $722M | · | $683M | $622M | $899M | · | $3.16B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $641M | $582M | $870M | · | $3.12B | |
| P/E | -1.3 | -1.0 | · | -5.1 | -1.3 | -1.8 | · | 0.2 | 0.4 | 5.4 | · | -0.0 | -0.0 | · | · | · | |
| P/S | 81.4 | 42.5 | · | 61.1 | 18.7 | 33.9 | · | · | · | · | · | · | · | · | · | · | |
| P/B | 1.9 | 1.4 | · | 4.5 | 1.0 | 1.2 | · | 1.7 | 1.6 | 4.8 | · | 18.6 | 13.7 | 16.9 | · | 38.5 | |
| P / Tangible Book | 1.9 | 1.4 | · | 4.5 | 1.0 | 1.2 | · | 1.7 | 1.6 | 4.8 | · | 18.6 | 13.7 | 16.9 | · | 38.5 | |
| P / Cash Flow | · | -10.2 | · | · | · | -6.7 | · | · | · | -33.0 | · | · | · | -63.6 | · | · | |
| Earnings Yield | -75.9% | -103.2% | · | -19.6% | -77.9% | -54.1% | · | 421.6% | 230.5% | 18.5% | · | -2306.5% | -2093.5% | · | · | · |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | $6M | $2M | $0 | $0 | $14M |
| Margine Operativo % | -1906.4% | -4047.1% | · | · | -597.3% |
| Utile netto | $-117M | $-84M | $-81M | $-58M | $-85M |
| EPS Diluito | $-12.48 | $-9.37 | $-53.08 | $-227.42 | · |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | · | · | · | · | 0.0 |
| Rapporto corrente | 6.9 | 8.8 | 8.9 | · | 11.8 |
| Quick Ratio | 6.3 | 8.4 | 8.5 | · | 7.0 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-79M | $-78M | $-75M | · | $-79M |
Proprietari istituzionali (13F) 114 filer · $213.2M totale · Aggiornato al 30 Settembre 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
114
Valore detenuto
$213.2M
Nuove posizioni
18
Posizioni chiuse
11
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 18 (-15 vs trimestre precedente) | 11 (0 vs trimestre precedente) | 47 (+13 vs trimestre precedente) | 22 (-1 vs trimestre precedente) | +1.3M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| Lynx1 Capital Management LP | $20.274.741 | 1.538.296 | 9,51% | Azioni |
| Qiming U.S. Ventures Management, LLC | $17.627.591 | 368.085 | 8,27% | Azioni |
| NEA Management Company, LLC | $17.106.230 | 1.297.893 | 8,02% | Azioni |
| Venrock Adviser, LLC | $13.305.210 | 1.009.500 | 6,24% | Azioni |
| Atlas Venture Life Science Advisors, LLC | $12.690.811 | 962.884 | 5,95% | Azioni |
| Balyasny Asset Management L.P. | $12.544.500 | 951.783 | 5,88% | Azioni |
| BlackRock, Inc. | $10.776.245 | 817.621 | 5,05% | Azioni |
| Affinity Asset Advisors, LLC | $9.316.995 | 706.904 | 4,37% | Azioni |
| Nantahala Capital Management, LLC | $8.699.274 | 660.036 | 4,08% | Azioni |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $7.129.958 | 540.968 | 3,34% | Azioni |
| ADAR1 Capital Management, LLC | $7.117.912 | 540.054 | 3,34% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $5.993.974 | 454.778 | 2,81% | Azioni |
| Driehaus Capital Management LLC | $5.931.593 | 450.045 | 2,78% | Azioni |
| TCG Crossover Management, LLC | $5.486.847 | 416.301 | 2,57% | Azioni |
| Kalehua Capital Management LLC | $5.338.427 | 405.040 | 2,50% | Azioni |
| Siren, L.L.C. | $4.582.923 | 347.718 | 2,15% | Azioni |
| AQR CAPITAL MANAGEMENT LLC | $3.940.478 | 298.974 | 1,85% | Azioni |
| VANGUARD GROUP INC | $3.922.009 | 489.639 | 1,84% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $3.913.148 | 296.870 | 1,84% | Azioni |
| 72 Investment Holdings, LLC | $3.648.633 | 276.831 | 1,71% | Azioni |
| STATE STREET CORP | $3.065.497 | 232.587 | 1,44% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.946.402 | 223.551 | 1,38% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $2.346.976 | 178.071 | 1,10% | Azioni |
| JPMORGAN CHASE & CO | $1.645.760 | 124.726 | 0,77% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $1.560.960 | 118.434 | 0,73% | Azioni |
| GOLDMAN SACHS GROUP INC | $1.541.836 | 116.983 | 0,72% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $1.456.706 | 110.524 | 0,68% | Azioni |
| UBS Group AG | $1.389.871 | 105.453 | 0,65% | Azioni |
| NORTHERN TRUST CORP | $1.161.013 | 88.089 | 0,54% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $987.195 | 74.901 | 0,46% | Azioni |
| CITADEL ADVISORS LLC | $935.780 | 71.000 | 0,44% | Opzione Call |
| F/m Investments LLC | $837.747 | 63.562 | 0,39% | Azioni |
| EMERALD MUTUAL FUND ADVISERS TRUST | $837.747 | 63.562 | 0,39% | Azioni |
| Walleye Capital LLC | $715.529 | 54.289 | 0,34% | Azioni |
| Quantinno Capital Management LP | $694.850 | 52.720 | 0,33% | Azioni |
| BANK OF AMERICA CORP /DE/ | $681.498 | 51.707 | 0,32% | Azioni |
| RAYMOND JAMES FINANCIAL INC | $644.765 | 48.920 | 0,30% | Azioni |
| XTX Topco Ltd | $630.254 | 47.819 | 0,30% | Azioni |
| CITADEL ADVISORS LLC | $532.340 | 40.390 | 0,25% | Azioni |
| FMR LLC | $513.691 | 38.975 | 0,24% | Azioni |
| BOOTHBAY FUND MANAGEMENT, LLC | $472.543 | 35.853 | 0,22% | Azioni |
| D. E. Shaw & Co., Inc. | $450.927 | 34.213 | 0,21% | Azioni |
| Jump Financial, LLC | $446.881 | 33.906 | 0,21% | Azioni |
| Bank of New York Mellon Corp | $418.196 | 31.730 | 0,20% | Azioni |
| AIHC Capital Management Ltd | $398.893 | 30.265 | 0,19% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $383.538 | 29.100 | 0,18% | Opzione Call |
| Mariner, LLC | $367.824 | 27.908 | 0,17% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $346.028 | 26.254 | 0,16% | Azioni |
| PANAGORA ASSET MANAGEMENT INC | $337.039 | 25.572 | 0,16% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $317.770 | 24.110 | 0,15% | Azioni |
Attivisti e proprietari del 5%+ 2 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Atlas Venture Fund XI, L.P., Atlas Venture Associates XI, L.P., Atlas Venture Associates XI, LLC, Atlas Venture Opportunity Fund II, L.P., Atlas Venture Associates Opportunity II, L.P., Atlas Venture Associates Opportunity II, LLC ×2 depositi | 04 Agosto 2026 | 4,90% | Modifica | · | SEC |
| New Enterprise Associates 17, L.P., NEA Partners 17, L.P., NEA 17 GP, LLC, Forest Baskett, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Edward T. Mathers, Scott D. Sandell, Paul Walker, Rick Yang ×3 depositi | 12 Marzo 2026 | 9,90% | Modifica | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 40 insider · 15 dirigenti · 13 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Vineet Agarwal | Chief Financial Officer | 03 Febbraio 2025 A | 0 | 0 | 0 | $0 |
| Peter P. Pfreundschuh | Chief Financial Officer | 22 Febbraio 2022 S | 8.927 | 0 | 0 | $0 |
| Todd Chappell | Chief Operating Officer | 15 Luglio 2026 A | 24.464 | 0 | 1 | $-34.309 |
| Oliver Dolan | Senior Vice President, Finance | 11 Settembre 2026 S | 16.241 | 0 | 4 | $-136.047 |
| Loic A Vincent | Chief Scientific Officer | 15 Luglio 2026 A | 25.797 | 0 | 1 | $-37.017 |
| Jeffrey Cerio | General Counsel | 15 Luglio 2026 A | 41.793 | 0 | 1 | $-71.575 |
| Olukemi Olugemo | Chief Medical Officer | 03 Febbraio 2025 A | · | 0 | 0 | $0 |
| Shelby J. Walker | Senior Vice President, General Counsel and Secretary | 03 Novembre 2023 A | · | 0 | 0 | $0 |
| Steve Colletti | Chief Scientific Officer | 03 Novembre 2023 A | · | 0 | 0 | $0 |
| Richard J. Mitrano | VP Finance & Operations | 21 Agosto 2023 S | 48.457 | 0 | 0 | $0 |
| Christopher R. Loose | Chief Scientific Officer | 28 Luglio 2023 S | 183.650 | 0 | 0 | $0 |
| Quentin Mccubbin | Chief Manufacturing Officer | 26 Gennaio 2023 A | 38.340 | 0 | 0 | $0 |
| Wendy S Arnold | Chief People Officer | 26 Gennaio 2023 A | 21.186 | 0 | 0 | $0 |
| Carl Lebel | Chief Development Officer | 26 Gennaio 2023 A | 26.343 | 0 | 0 | $0 |
| Michael Bookman | General Counsel and Secretary | 20 Aprile 2021 A | · | 0 | 0 | $0 |
| FORMELA JEAN FRANCOIS | Direttore | 14 Settembre 2026 S | 132.650 | 0 | 24 | $-5.160.282 |
| Rachel Meyers | Direttore | 10 Giugno 2026 A | · | 0 | 0 | $0 |
| Katharine Knobil | Direttore | 10 Giugno 2026 A | · | 0 | 0 | $0 |
| Ali Behbahani | Direttore | 10 Giugno 2026 A | 1.297.893 | 0 | 0 | $0 |
| Timothy R Pearson | Direttore | 10 Giugno 2026 A | · | 0 | 0 | $0 |
| Nessan Bermingham | Direttore | 10 Giugno 2026 A | 35.114 | 0 | 0 | $0 |
| David L. Lucchino | Direttore | 11 Giugno 2024 A | 22.150 | 0 | 0 | $0 |
| Michael Huang | Direttore | 17 Agosto 2022 D | · | 0 | 0 | $0 |
| Cynthia L Feldmann | Direttore | 17 Agosto 2022 D | · | 0 | 0 | $0 |
| Robert Langer | Direttore | 17 Agosto 2022 D | 214.326 | 0 | 0 | $0 |
| Joel S Marcus | Direttore | 17 Agosto 2022 D | 307.116 | 0 | 0 | $0 |
| BARBERICH TIMOTHY J | Direttore | 17 Agosto 2022 D | 80.650 | 0 | 0 | $0 |
| Marc A Cohen | Direttore | 21 Giugno 2022 A | 605.820 | 0 | 0 | $0 |
| Rick Yang | Proprietario del 10% | 10 Marzo 2026 P | 1.297.893 | 2 | 0 | $5.000.000 |
| Carmen Chang | Proprietario del 10% | 10 Marzo 2026 P | 1.297.893 | 2 | 0 | $5.000.000 |
| Mohamad Makhzoumi | Proprietario del 10% | 10 Marzo 2026 P | 1.297.893 | 2 | 0 | $5.000.000 |
| Anthony A. Florence, Jr. | Proprietario del 10% | 10 Marzo 2026 P | 1.297.893 | 2 | 0 | $5.000.000 |
| Paul Walker | Proprietario del 10% | 10 Marzo 2026 P | 1.297.893 | 2 | 0 | $5.000.000 |
| Edward T. Mathers | Proprietario del 10% | 10 Marzo 2026 P | 1.297.893 | 2 | 0 | $5.000.000 |
| Forest Baskett | Proprietario del 10% | 10 Marzo 2026 P | 1.297.893 | 2 | 0 | $5.000.000 |
| Scott D. Sandell | Proprietario del 10% | 10 Marzo 2026 P | 1.297.893 | 2 | 0 | $5.000.000 |
| Alexandria Venture Investments, LLC | Proprietario del 10% | 07 Ottobre 2019 C | 956.175 | 0 | 0 | $0 |
| William J. Mclean | Proprietario del 10% | 02 Ottobre 2019 A | · | 0 | 0 | $0 |
| Ram Aiyar | · | 04 Agosto 2026 S | 69.046 | 0 | 2 | $-259.567 |
| Dana Charles Hilt | · | 20 Aprile 2021 A | · | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 15 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| IWC · iShares Trust | 0,03% | 38.277 SH | 11 Settembre 2026 | Giornaliero |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 7.950 SH | 19 Agosto 2026 | Giornaliero |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,01% | 2.113 SH | 02 Ottobre 2026 | Giornaliero |
| IWO · iShares Trust | 0,01% | 58.538 SH | 11 Settembre 2026 | Giornaliero |
| IWM · iShares Trust | 0,00% | 281.853 SH | 11 Settembre 2026 | Giornaliero |
| RSSL · Global X Funds | 0,00% | 5.318 NS | 31 Luglio 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 9.978 NS | 31 Luglio 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 3.332 SH | 03 Settembre 2026 | Giornaliero |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 135.396 SH | 19 Agosto 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 311.262 SH | 19 Agosto 2026 | Giornaliero |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 63.717 SH | 19 Agosto 2026 | Giornaliero |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.170 SH | 19 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 428 SH | 19 Agosto 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,00% | 28.271 SH | 19 Agosto 2026 | Giornaliero |
| IWN · iShares Trust | · | 82.104 SH | 11 Settembre 2026 | Giornaliero |
KRRO Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 18 analisti
COMPRA
Target mediano
$21.50
+123,0%
5 27,8%
Acquisto forte
11 61,1%
Compra
2 11,1%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
10 analisti · 2026-09-30Target medio $20.20 +109,5%
← Sotto tutti i target
Prezzo attuale $9.64
Basso$10.00
Media$20.20
Alto$30.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| KRRO | $75M | -0.6 | 181.5% | -1834.5% | -140.8% | · |
| NERV | $174M | -0.1 | · | · | 339.5% | · |
| TNXP | $200M | -1.1 | 29.8% | -946.2% | -60.0% | · |
| ABOS | $128M | -1.1 | · | · | -129.4% | · |
| HUMA | · | · | · | · | · | · |
| PMVP | $67M | -0.8 | -40.5% | -1226.8% | -63.4% | · |
| OTLK | $57M | -0.6 | · | -4416.2% | 193.1% | 4.0% |
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | · |
| CBUS | · | -0.6 | -14.6% | -3492.3% | -223.0% | · |
| CRBU | $151M | -1.0 | 11.7% | -1327.4% | -102.8% | · |
Ultime notizie Notizie recenti che menzionano questa società
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 6, 2026